Clinical Development and Medical Affairs

Novartis is driven by innovation and how we can help improve and extend patients’ lives.

Explore our pipeline, clinical trials, and how we are reimagining medicine at Novartis.


View our broad research portfolio with innovative compounds in all phases of development.

Clinical Trials

Our research strategy aims to increase collaboration across traditional scientific and organizational boundaries, and focus on powerful new technologies that have the potential to help produce therapeutic breakthroughs.

Working closely with the care community, Novartis is currently conducting a number of clinical trials. We are committed to finding new treatment options for patients with cancer and hematologic diseases.

All compounds are either investigational or being studied for new indications. Efficacy and safety have not been established. There is no guarantee that they will become commercially available.

Featured Clinical Trials

Medical Information

We are committed to providing the most up-to-date, accurate, and timely medical information to health care professionals.

Submit a Medical Inquiry

For additional information, please contact us at: 1-844-662-4636Monday through Friday, 8:30 am to 5:00 pm ET.

Medical Information Mobile App

The Novartis Medical Information application provides health care professionals with accurate, and timely medical information.

Download on the App Store®

Download on Google Play™

Independent Medical Education

Novartis Oncology discovers and develops innovative products to treat patients with cancer, and hematologic, and rare diseases. Novartis is committed to the advancement of these goals through professional education.

The Novartis Oncology Office of Grants and Education (OGE) supports independent accredited and nonaccredited medical education programs intended to provide nonpromotional, current scientific information to US health care professionals and to improve patient care. Supported programs must be compliant with all applicable legal and regulatory guidelines, and be consistent with federal laws and regulations and the ethical standards under which Novartis Pharmaceuticals Corporation (NPC) conducts business. Funding may never be linked to prescribing, purchasing, formulary status, or reimbursement activities.

For more information on the grants process or to submit an educational grant request, please visit the Novartis Grants Central Station website.

Oncology Grants and Education
OGE only manages grant requests for activities taking place in the United States.